Metrics to compare | 600161 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship600161PeersSector | |
|---|---|---|---|---|
P/E Ratio | 27.1x | 35.1x | −0.4x | |
PEG Ratio | −0.76 | 0.03 | 0.00 | |
Price/Book | 2.2x | 1.9x | 2.6x | |
Price / LTM Sales | 4.4x | 5.7x | 3.1x | |
Upside (Analyst Target) | 46.1% | 32.6% | 50.8% | |
Fair Value Upside | Unlock | 18.9% | 7.8% | Unlock |
Beijing Tiantan Biological Products Co., Ltd. engages in the research and development, manufacture, sale, and marketing of blood products in China and internationally. Its products include human serum albumin; intravenous human immunoglobulin; rabies immunoglobulin; tetanus immunoglobulin; hepatitis B immunoglobulin; freeze-dried intravenous hepatitis B human immunoglobulin; histamine human immunoglobulin; human prothrombin complex concentrate; lyophilized intravenous hepatitis B immunoglobulin; human coagulation factors VIII; human fibrinogen; recombinant human coagulation factor VIII for injection; and other blood products. The company was founded in 1966 and is headquartered in Beijing, China.